A Phase I, Randomized, Observer-blind, Comparator-controlled, Study of the Safety and Immunogenicity of StreptAnova Vaccine in Healthy Adults Age ≥ 18 - 50 Years
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2017
At a glance
- Drugs Streptococcal A vaccine (Primary)
- Indications Streptococcal infections
- Focus Adverse reactions
- 17 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 17 Jan 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Mar 2017.
- 17 Jan 2017 Status changed from recruiting to active, no longer recruiting.